Pyramidal tract Wallerian degeneration has been detected on magnetic resonance imaging (MRI) as T2-weighted high-intensity areas. We analyzed the relation between the extent of brain stem Wallerian ...

Source Reference: Shor R, et al "Glucagon-like peptide-1 receptor agonists and risk of neovascular age-related macular degeneration" JAMA Ophthalmol 2025; DOI: 10.1001/jamaophthalmol.2025.1455.

Macular degeneration usually refers to the age-related degenerative changes in the retina that can result in loss of central vision. It is caused by abnormal blood vessel growth (a condition ...

A study of people with diabetes found the risk of macular degeneration remained low, but was 0.2% in people taking GLP-1s, 0.1% in those who didn't.

TOPLINE: Patients with diabetes using glucagon-like peptide 1 receptor agonists (GLP-1 RAs) may face more than twice the risk for developing neovascular age-related macular degeneration compared ...

News-Medical is your trusted source of Macular Degeneration news, articles and research for doctors, patients, and families.

Understand how knee osteoarthritis leads to joint degeneration, reduced mobility, and chronic pain. Find out diagnosis methods and treatment options available.

The UAB Department of Ophthalmology and Visual Sciences is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, and ...

Further, histopathological evidence of Wallerian-like axonal degeneration has been observed in nerve biopsies of patients treated with a range of chemotherapies including vincristine, 59 60 ...

BACKGROUND: Neuronal plasticity after stroke occurs predominantly within the first few months. However, its persistence and distribution in the chronic phase remain unclear. This study investigated ...

GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with type 2 diabetes, according to a new study. The risk increased the ...